Differences in reporting Pearl Indices in the United States and Europe: Focus on a 91-day extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/28835

Title:	Differences in reporting Pearl Indices in the United States and Europe: Focus on a 91-day extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.
Authors:	Lobo Abascal, Paloma Luzar-Stiffler, Vesna Giljanovic, Silvana Howard, Brandon Weiss, Herman Trussell, James View more
Keywords:	Combined oral contraceptive Extended-regimen Pearl Index View more
Mesh:	Contraception Behavior Contraceptives, Oral, Combined Drug Administration Schedule Ethinyl Estradiol Europe Female Humans Levonorgestrel Medication Adherence Patient Satisfaction Pregnancy United States View more
Issue Date:	2016
Citation:	Eur J Contracept Reprod Health Care.2016;(21)1:88-91
Abstract:	Regulatory agencies in the United States (US) and Europe differ in requirements for defining pregnancies after the last dose of oral contraceptive, sometimes resulting in discrepant Pearl Indices (PIs) for the same product despite identical clinical data. This brief report highlights one such example, a 91-day extended-regimen combined oral contraceptive (COC).
PMID:	26115381
URI:	https://hdl.handle.net/20.500.12530/28835
Rights:	openAccess
Appears in Collections:	Hospitales > H. U. Infanta Sofía > Artículos

Files in This Item:

File	Description	Size	Format
PMC5533102.pdf		42.38 kB	Adobe PDF	View/Open